SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 223 filers reported holding SEATTLE GENETICS INC in Q3 2015. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,879,000 | +40.0% | 50,480 | +21.6% | 0.03% | +26.9% |
| Q2 2020 | $7,055,000 | +64.4% | 41,518 | +11.6% | 0.03% | +36.8% |
| Q1 2020 | $4,292,000 | +2.5% | 37,207 | +1.5% | 0.02% | +26.7% |
| Q4 2019 | $4,187,000 | +58.4% | 36,640 | +18.3% | 0.02% | +50.0% |
| Q3 2019 | $2,644,000 | +23.3% | 30,962 | -0.1% | 0.01% | +11.1% |
| Q2 2019 | $2,144,000 | -10.2% | 30,984 | -4.9% | 0.01% | -10.0% |
| Q1 2019 | $2,387,000 | +32.0% | 32,586 | +2.1% | 0.01% | +11.1% |
| Q4 2018 | $1,808,000 | -19.0% | 31,901 | +10.2% | 0.01% | -10.0% |
| Q3 2018 | $2,232,000 | +19.5% | 28,952 | +2.8% | 0.01% | +11.1% |
| Q2 2018 | $1,868,000 | +34.4% | 28,150 | +6.0% | 0.01% | +28.6% |
| Q1 2018 | $1,390,000 | -0.9% | 26,562 | +1.4% | 0.01% | 0.0% |
| Q4 2017 | $1,402,000 | -6.0% | 26,207 | -4.4% | 0.01% | -12.5% |
| Q3 2017 | $1,491,000 | -9.0% | 27,404 | -13.5% | 0.01% | -20.0% |
| Q2 2017 | $1,639,000 | -17.5% | 31,693 | +0.3% | 0.01% | -28.6% |
| Q1 2017 | $1,986,000 | +31.9% | 31,602 | +10.7% | 0.01% | +16.7% |
| Q4 2016 | $1,506,000 | +10.2% | 28,549 | +12.8% | 0.01% | +20.0% |
| Q3 2016 | $1,367,000 | +45.3% | 25,307 | +8.6% | 0.01% | +42.9% |
| Q2 2016 | $941,000 | +28.0% | 23,302 | +11.3% | 0.01% | +16.7% |
| Q1 2016 | $735,000 | +12.4% | 20,938 | +43.7% | 0.01% | 0.0% |
| Q4 2015 | $654,000 | +44.4% | 14,568 | +23.9% | 0.01% | +20.0% |
| Q3 2015 | $453,000 | -7.6% | 11,755 | +16.2% | 0.01% | 0.0% |
| Q2 2015 | $490,000 | +56.1% | 10,120 | +19.9% | 0.01% | +25.0% |
| Q3 2014 | $314,000 | -9.0% | 8,442 | -6.5% | 0.00% | -20.0% |
| Q2 2014 | $345,000 | +17.3% | 9,026 | +40.1% | 0.01% | +25.0% |
| Q1 2014 | $294,000 | +15.3% | 6,444 | +0.9% | 0.00% | 0.0% |
| Q4 2013 | $255,000 | -1.9% | 6,385 | +7.6% | 0.00% | -20.0% |
| Q3 2013 | $260,000 | – | 5,935 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |